|
|
Article: Emerging Opportunities in Controlled-Release Generic Drugs: New Report Identifies 30 Controlled-Release Drugs Valued at US$15 Billion.(Report)
- Article from:
- Biotech Week
- Article date:
- September 16, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Research and Markets (http://www.researchandmarkets.com/research/a4ffa3/emerging_opportuni) has announced the addition of the "Emerging Opportunities in Controlled-Release Generic Drugs" report to their offering (see also Research and Markets).
This new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium term.
From emerging specialist companies to established generic producers, alternative drug delivery technologies are increasingly being seen as a route to a competitive edge in the generics industry.
While controlled-release products have traditionally been ...